You can buy or sell Cabaletta Bio and other stocks, options, and ETFs commission-free!
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
52 Week High
52 Week Low
— per share
-$0.41 per share